SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-07-069705
Filing Date
2007-12-13
Accepted
2007-12-13 17:42:02
Documents
2
Period of Report
2007-12-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7987
2 POA DOCUMENT poa.txt EX-24.4_215469 2961
  Complete submission text file 0001209191-07-069705.txt   12902
Mailing Address 4848 LOOP CENTRAL DRIVE SUITE 700 HOUSTON TX 77081
Business Address 4848 LOOP CENTRAL DRIVE SUITE 700 HOUSTON TX 77081 7137968822
ENCYSIVE PHARMACEUTICALS INC (Issuer) CIK: 0000887023 (see all company filings)

IRS No.: 133532643 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4848 LOOP CENTRAL DRIVE SUITE 700 HOUSTON TX 77081
Business Address 713-578-6525
KEYSER D JEFFREY (Reporting) CIK: 0001393516 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-20117 | Film No.: 071305412